Skip to content
check_circle Active

Oxford Drug Design Limited

Company Number: 04305857 · Private Limited Company

open_in_new

Trust Score

100 / 100
High Trust 7/7 passed
fact_check Filing

Filing Compliance

Up to date

schedule Age

Company Age

24 years

groups Officers

Active Directors

6

info

Trust Score is calculated from 7 public data checks including filing history, company age, director appointments, and compliance status. Not a credit check.

business Type

Private Limited Company

event Incorporated

17 October 2001

24 years ago

location_on Address

Oxford Centre For Innovation Blue Boar Court, 9 Alfred Street, Oxford, OX1 4EH, England

category Industry

SIC 72110

info About Oxford Drug Design Limited

Oxford Drug Design Limited is a private limited company registered in the United Kingdom with company number 04305857. The company was incorporated on 17 October 2001, making it 24 years old. The company is currently active.

Oxford Drug Design Limited operates in the sic 72110 sector.

The company's registered office is located at Oxford Centre For Innovation Blue Boar Court, 9 Alfred Street, Oxford, OX1 4EH, England.

Oxford Drug Design Limited currently has 6 active officers, including HARGREAVES, Sarah Jane, AYZIKOVICH, Boris, Dr, BOYLE, Robert George and 3 others.

Filing History

30 May 2026
MA

Memorandum Articles

13 April 2026
SH01

Capital Allotment Shares

9 April 2026
SH01

Capital Allotment Shares

6 January 2026
SH01

Capital Allotment Shares

4 November 2025
AD02

Change Sail Address Company With Old Address New Address

Show 20 more filings
3 November 2025

CS01 — Confirmation Statement With Updates

3 November 2025

AD04 — Move Registers To Registered Office Company With New Address

6 August 2025

AA — Accounts With Accounts Type Total Exemption Full

20 June 2025

RP04SH01 — Second Filing Capital Allotment Shares

18 June 2025

SH01 — Capital Allotment Shares

23 April 2025

SH19 — Capital Statement Capital Company With Date Currency Figure

23 April 2025

SH20 — Legacy

23 April 2025

CAP-SS — Legacy

23 April 2025

RESOLUTIONS — Resolution

10 April 2025

AD01 — Change Registered Office Address Company With Date Old Address New Address

24 February 2025

TM01 — Termination Director Company With Name Termination Date

29 October 2024

CS01 — Confirmation Statement With Updates

11 October 2024

AP01 — Appoint Person Director Company With Name Date

3 May 2024

AA — Accounts With Accounts Type Total Exemption Full

6 November 2023

CS01 — Confirmation Statement With Updates

View all 25 filings on Companies House →

Company Timeline

SH01

capital allotment shares

SH01

capital allotment shares

SH01

capital allotment shares

CS01

confirmation statement with updates

AA

accounts with accounts type total exemption full

Show 54 more events

SH01

AD01

TM01

RICHARDS, William Graham, Professor resigned

CS01

AP01

AYZIKOVICH, Boris, Dr appointed

FORD, David Ian resigned

HARGREAVES, Sarah Jane appointed

COOPER, Nikki Marie resigned

IP2IPO SERVICES LIMITED resigned

LYTH, Oliver Robert appointed

LYTH, Oliver Robert resigned

IP2IPO SERVICES LIMITED appointed

COOPER, Nikki Marie appointed

HADDLETON & CO LIMITED resigned

ROTH, Alan David, Dr appointed

HADDLETON & CO LIMITED appointed

IP2IPO SERVICES LIMITED resigned

IP2IPO SERVICES LIMITED resigned

help Frequently Asked Questions

Is Oxford Drug Design Limited still active?

Oxford Drug Design Limited is currently active. Incorporated on 17 October 2001, 24 years ago.

Can I trust Oxford Drug Design Limited?

Based on publicly available data, Oxford Drug Design Limited has a trust score of 100/100 (high trust). 7 out of 7 checks passed. This is not a credit check — always do your own due diligence.

Who are the directors?

Oxford Drug Design Limited has 6 active directors: HARGREAVES, Sarah Jane, AYZIKOVICH, Boris, Dr, BOYLE, Robert George and 3 more.

database

Data from Companies House. Crown Copyright. Open Government Licence v3.0.